These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33434668)

  • 1. Epidemiology of COVID-19 in Mexico: Symptomatic profiles and presymptomatic people.
    Fernández-Rojas MA; Luna-Ruiz Esparza MA; Campos-Romero A; Calva-Espinosa DY; Moreno-Camacho JL; Langle-Martínez AP; García-Gil A; Solís-González CJ; Canizalez-Román A; León-Sicairos N; Alcántar-Fernández J
    Int J Infect Dis; 2021 Mar; 104():572-579. PubMed ID: 33434668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroconversion dynamic and SARS-CoV-2 seropositivity in unvaccinated population during the first and second outbreaks in Mexico.
    Fernández-Rojas MA; Luna-Ruiz Esparza MA; Campos-Romero A; Calva-Espinosa DY; Moreno-Camacho JL; Mendlovic F; Plett-Torres T; Alcántar-Fernández J
    Sci Rep; 2022 Mar; 12(1):5241. PubMed ID: 35347208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Adoption of Longitudinal Surveillance for SARS-CoV-2 among Staff in Long-Term Care Facilities: Prevalence, Virologic and Sequence Analysis.
    Gallichotte EN; Quicke KM; Sexton NR; Fitzmeyer E; Young MC; Janich AJ; Dobos K; Pabilonia KL; Gahm G; Carlton EJ; Ebel GD; Ehrhart N
    Microbiol Spectr; 2021 Dec; 9(3):e0100321. PubMed ID: 34756092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2.
    Wohl DA; Barzin AH; Napravnik S; Davy-Mendez T; Smedberg JR; Thompson CM; Ruegsegger L; Gilleskie M; Weber DJ; Whinna HC; Miller MB
    PLoS One; 2021; 16(12):e0260879. PubMed ID: 34890441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic and features of SARS-CoV-2 infection in Gabon.
    Mveang Nzoghe A; Padzys GS; Maloupazoa Siawaya AC; Kandet Yattara M; Leboueny M; Avome Houechenou RM; Bongho EC; Mba-Mezeme C; Mvoundza Ndjindji O; Biteghe-Bi-Essone JC; Boulende A; Essone PN; Ndong Sima CAA; Minkobame U; Zang Eyi C; Ndeboko B; Voloc A; Meye JF; Ategbo S; Djoba Siawaya JF
    Sci Rep; 2021 May; 11(1):9672. PubMed ID: 33958601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.
    Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA
    Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches - March-April 2020.
    Migisha R; Kwesiga B; Mirembe BB; Amanya G; Kabwama SN; Kadobera D; Bulage L; Nsereko G; Wadunde I; Tindyebwa T; Lubwama B; Kagirita AA; Kayiwa JT; Lutwama JJ; Boore AL; Harris JR; Bosa HK; Ario AR
    Global Health; 2020 Nov; 16(1):114. PubMed ID: 33239041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean.
    Mattar S; Martinez-Bravo C; Rivero R; Contreras H; Faccini-Martínez ÁA; Guzman-Teran C; Galeano K; Alvis-Guzman N; Contreras V; Arrieta G; Gonzalez-Tous M; Miranda J; Ospina M; Camargo-Assis F; Mercado-Reyes M; Garay E; Garcia-Perez A; Lopez Y; Tique V
    Ann Clin Microbiol Antimicrob; 2020 Dec; 19(1):58. PubMed ID: 33287846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea.
    Lee S; Kim T; Lee E; Lee C; Kim H; Rhee H; Park SY; Son HJ; Yu S; Park JW; Choo EJ; Park S; Loeb M; Kim TH
    JAMA Intern Med; 2020 Nov; 180(11):1447-1452. PubMed ID: 32780793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low prevalence of asthma in Mexican children and adults with a positive rtRT-PCR test for SARS-CoV-2: a cross-sectional study during the 2020 pandemic.
    Bedolla-Barajas M; Morales-Romero J; Bedolla-Pulido TR; Meza-López C; Robles-Figueroa M; Pulido-Guillén NA; Orozco-Alatorre LG; Andrade-Castellanos CA
    Allergol Immunopathol (Madr); 2021; 49(3):1-7. PubMed ID: 33938182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comprehensive Descriptive Epidemiological and Clinical Analysis of SARS-CoV-2 in West-Mexico during COVID-19 Pandemic 2020.
    Viera-Segura O; Vega-Magaña N; García-Chagollán M; Peña-Rodríguez M; Muñoz-Sánchez G; Carranza-Aranda AS; Llamas-Covarrubias IM; Ramos-Solano M; Mora-Mora J; Díaz-Palomera CD; León GE; Zepeda-Nuño JS; Santillán-López E; García-Arellano S; Hernández-Silva CD; Zerpa-Hernandez DA; Muñoz-Rios G; Rodríguez-Sanabria JS; Muñoz-Valle JF
    Int J Environ Res Public Health; 2021 Oct; 18(20):. PubMed ID: 34682388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance and clinical implications of rapid SARS-CoV-2 antigen testing in Mexico using real-world nationwide COVID-19 registry data.
    Bello-Chavolla OY; Antonio-Villa NE; Fernández-Chirino L; Guerra EC; Fermín-Martínez CA; Márquez-Salinas A; Vargas-Vázquez A; Bahena-López JP
    PLoS One; 2021; 16(8):e0256447. PubMed ID: 34464393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
    Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
    Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
    Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
    Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 in the Context of Inborn Errors of Immunity: a Case Series of 31 Patients from Mexico.
    Castano-Jaramillo LM; Yamazaki-Nakashimada MA; O'Farrill-Romanillos PM; Muzquiz Zermeño D; Scheffler Mendoza SC; Venegas Montoya E; García Campos JA; Sánchez-Sánchez LM; Gámez González LB; Ramírez López JM; Bustamante Ogando JC; Vásquez-Echeverri E; Medina Torres EA; Lopez-Herrera G; Blancas Galicia L; Berrón Ruiz L; Staines-Boone AT; Espinosa-Padilla SE; Segura Mendez NH; Lugo Reyes SO
    J Clin Immunol; 2021 Oct; 41(7):1463-1478. PubMed ID: 34114122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening Testing for SARS-CoV-2 upon Admission to Rehabilitation Hospitals in a High COVID-19 Prevalence Community.
    Kirshblum SC; DeLauter G; Lopreiato MC; Pomeranz B; Dawson A; Hammerman S; Gans BM
    PM R; 2020 Oct; 12(10):1009-1014. PubMed ID: 32700434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic, Presymptomatic, and Asymptomatic Transmission of SARS-CoV-2 in a University Student Population, August-November 2020.
    Krieg SJ; Schnur JJ; Miranda ML; Pfrender ME; Chawla NV
    Public Health Rep; 2022; 137(5):1023-1030. PubMed ID: 35848117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.